Showing results (761-770 of 2,315) with videos related to

Sort By:
Pageof 232
Frontiers in Neurology|September 25, 2023
Switching to second line MS disease-modifying therapies is associated with decreased relapse rateJames John Marriott, Okechukwu Ekuma, Randall Fransoo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 12, 2026
Ofatumumab and enteroviral encephalitis: a severe infectious complication as a class effect with anti-CD20 therapiesDalia L Rotstein, Sheliza Halani, Peter Vadas, et al.
Journal of Separation Science|July 15, 2005
Analysis of methoxypyrazines in wine using headspace solid phase microextraction with isotope dilution and comprehensive two-dimensional gas chromatographyDanielle Ryan, Peter Watkins, Jason Smith, et al.
Cancer Immunology, Immunotherapy : CII|October 18, 2002
Adjuvants and the promotion of Th1-type cytokines in tumour immunotherapyKeith Dredge, J Blake Marriott, Stephen M Todryk, et al.
Cardiovascular and Interventional Radiology|January 30, 2002
Expandable metal stents for the palliation of malignant gastroduodenal obstructionR Razzaq, H U Laasch, R England, et al.
FEMS Microbiology Letters|June 1, 1990
Separation of plasmid-mediated extended spectrum beta-lactamases by fast protein liquid chromatography (FPLC system)D J Payne, J Hood, M S Marriott, et al.
Antimicrobial Agents and Chemotherapy|March 7, 2012
Posaconazole exposure-response relationship: evaluating the utility of therapeutic drug monitoringMichael J Dolton, John E Ray, Deborah Marriott, et al.
The European Respiratory Journal|January 1, 1990
The origin of DNA associated with mucus glycoproteins in cystic fibrosis sputumM I Lethem, S L James, C Marriott, et al.
Journal of Fish Biology|November 17, 2010
Age validation and growth of bluenose Hyperoglyphe antarctica using the bomb chronometer method of radiocarbon ageingP L Horn, H L Neil, L J Paul, et al.
Neurology|May 5, 2010
Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis [RETIRED]: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyJames J Marriott, Janis M Miyasaki, Gary Gronseth, et al.
Pageof 232